"UPMC Hillman Cancer Center - Monroeville (Medical Oncology) is a Cancer Treatment Center located in Monroeville.Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, UPMC Cancer Center - Monroeville conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 6 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 2 clinical trials were completed. i.e. 9.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UPMC Cancer Center - Monroeville" #1 sponsor was "National Cancer Institute (NCI)" with 14 trials, followed by "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "NRG Oncology" with 4 trials sponsored, "Pfizer" with 4 trials sponsored and "SWOG Cancer Research Network" with 4 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Cancer Center - Monroeville" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Cancer Center - Monroeville" are "Recurrent Lung Non-Small Cell Carcinoma" (4 trials), "Stage IIIA Lung Cancer AJCC v8" (3 trials), "Stage IIIB Lung Cancer AJCC v8" (3 trials), "Stage IV Lung Cancer AJCC v8" (3 trials) and "Stage IVA Lung Cancer AJCC v8" (3 trials). Many other conditions were trialed in "UPMC Cancer Center - Monroeville" in a lesser frequency.

Most popular intervention types in "UPMC Cancer Center - Monroeville" are "Drug" (34 trials), "Other" (18 trials), "Biological" (15 trials), "Radiation" (14 trials) and "Procedure" (13 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (12 trials), "Computed Tomography" (9 trials), "Questionnaire Administration" (9 trials), "Paclitaxel" (8 trials) and "Carboplatin" (7 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Cancer Center - Monroeville" are 29 trials for "All" genders, 7 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "UPMC Cancer Center - Monroeville". undefined are not yet recruiting, 18 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in UPMC Cancer Center - Monroeville, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Cancer Center - Monroeville, 1 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".